Cochlear (FRA:OC5) Non Operating Income: €-58 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OC5 Cochlear Ltd FRA:OC5
68 GF Score
Price €86.41
GF Value €186.50
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cochlear Non Operating Income?

Cochlear FRA:OC5 -1.85% 68 Non Operating Income is €-58 Mil as of Jun. 2026. GuruFocus rates FRA:OC5 with a GF Score™ of 68/100 and a GF Value™ of €186.50 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. Cochlear's Non Operating Income for the six months ended in Jun. 2026 was €-38 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was €-58 Mil.

Cochlear Non Operating Income Related Terms

Cochlear Non Operating Income Historical Data

* Premium members only.

The historical data trend for Cochlear's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cochlear Non Operating Income Chart

Cochlear Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.68 -2.04 -14.74 12.02 -59.17

Cochlear Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.67 8.89 3.73 -19.75 -37.94
FRA:OC5
68GF Score
Cochlear Ltd FRA:OC5
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cochlear Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-58 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of €-58 Mil mean?
Cochlear (FRA:OC5) has a Non Operating Income of €-58 Mil as of Jun. 2026. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Cochlear and its competitors.
Is Cochlear's Non Operating Income too high?
Cochlear's current Non Operating Income is €-58 Mil. Overall, Cochlear has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cochlear's Non Operating Income compare to ABT and SYK?
Cochlear's Non Operating Income of €-58 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Medical Devices & Instruments company?
A good Non Operating Income depends on the Medical Devices & Instruments industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Cochlear and its competitors. Cochlear's current Non Operating Income is €-58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cochlear stock overvalued right now?
Based on GuruFocus' analysis, Cochlear (FRA:OC5) is currently considered Significantly Undervalued. The stock's GF Value™ is €186.50, compared to a current price of €86.41 — trading 53.7% below its estimated fair value. The current Non Operating Income is €-58 Mil. Cochlear's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Cochlear (FRA:OC5), the current Non Operating Income is €-58 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cochlear (FRA:OC5) Overvalued in 2026?

Based on GuruFocus' analysis, Cochlear stock appears to be undervalued. The current stock price of €86.41 is trading 53.7% below its estimated GF Value™ of €186.50. GuruFocus considers Cochlear to be Significantly Undervalued.

Key valuation signals for FRA:OC5:

  • Non Operating Income: €-58 Mil
  • GF Value™: €186.50 vs. price of €86.41 (53.7% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the FRA:OC5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cochlear Business Description

Address 1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.
68GF Score

Get the complete analysis for FRA:OC5

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€86.41
Price
€186.50
GF Value